The Features of COVID-19’s Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria

COVID-19 and other infectious diseases can exacerbate the course of paroxysmal nocturnal hemoglobinuria (PNH). The efficacy and safety of the Gam-COVID-Vac vaccine in patients with PNH has not been adequately studied. A retrospective, observational, cohort, non-comparative study was performed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ptushkin, Vadim, Arshanskaya, Evgeniya, Vinogradova, Olga, Kudlay, Dmitry, Nikitin, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531158/
https://www.ncbi.nlm.nih.gov/pubmed/37754667
http://dx.doi.org/10.3390/hematolrep15030052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531158/
https://www.ncbi.nlm.nih.gov/pubmed/37754667
http://dx.doi.org/10.3390/hematolrep15030052

Ejemplares similares